HIV-1 infection and risk of tuberculosis after rifampicin treatment

Lancet. 2001 Mar 24;357(9260):957-8. doi: 10.1016/S0140-6736(05)71656-1.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibiotics, Antitubercular / therapeutic use*
  • HIV Infections / microbiology*
  • HIV-1*
  • Humans
  • Recurrence
  • Rifampin / therapeutic use*
  • Tuberculosis / drug therapy*
  • Tuberculosis / virology

Substances

  • Antibiotics, Antitubercular
  • Rifampin